Occlutech Holding AG, one of the world’s leading providers of minimally invasive structural heart disease devices, has appointed Jozef Bartunek, MD, PhD, as new Chief Medical Officer, thus expanding its Executive Management Team.
November 1, 2022
· 3 min read
